| http://www.w3.org/ns/prov#value | - Evidence for a benefit of danaparoid therapy in HIT has been provided by the studies summarised below.There is a on-going controversy over the appropriate dose of danaparoid in patients with uncomplicated HIT. Two small studies of 24 (Schenk et al, 2003) and 16 patients (Tardy-Poncet et al, 1999) reported favourable outcomes (one episode of venous thromboembolism in 44 treatment episodes) using 60
|
